MS Lennard
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
- Pharmacology 19
- Pharmacogenetics and Drug Metabolism 16
- Pharmacology and Obesity Treatment 6
- Plant-based Medicinal Research 3
-
- Drug-Induced Ocular Toxicity 7
- Partner nations
- United KingdomSri LankaUnited States
In The Last Decade
MS Lennard
30 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Pharmacology 714
- Pharmacology 363
- Analytical Chemistry 153
- Psychiatry and Mental health 223
- Biochemistry 97
Countries citing papers authored by MS Lennard
This map shows the geographic impact of MS Lennard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MS Lennard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MS Lennard more than expected).
Fields of papers citing papers by MS Lennard
This network shows the impact of papers produced by MS Lennard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MS Lennard. The network helps show where MS Lennard may publish in the future.
Co-authorship network
The 19 scholars most cited alongside MS Lennard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 24 | |
| 2 | 1994 | 19 | |
| 3 | The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Hit paper breakdown → | 1992 | 396 |
| 4 | 1990 | 25 | |
| 5 | 1989 | 15 | |
| 6 | 1989 | 11 | |
| 7 | 1988 | 12 | |
| 8 | 1985 | 11 | |
| 9 | 1985 | 18 | |
| 10 | 1985 | 60 | |
| 11 | 1984 | 15 | |
| 12 | 1984 | 27 | |
| 13 | 1984 | 10 | |
| 14 | 1984 | 61 | |
| 15 | 1984 | 4 | |
| 16 | 1984 | 4 | |
| 17 | 1982 | 18 | |
| 18 | 1981 | 73 | |
| 19 | 1978 | 7 | |
| 20 | 1977 | 2 |
About MS Lennard
MS Lennard is a scholar working on Pharmacology, Ophthalmology, Pharmacology, Endocrinology, Diabetes and Metabolism and Analytical Chemistry, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Cancer Treatment and Pharmacology (7 papers), Drug-Induced Ocular Toxicity (7 papers), Pharmacology and Obesity Treatment (6 papers), Analytical Chemistry and Chromatography (4 papers), Adrenal Hormones and Disorders (3 papers), Plant-based Medicinal Research (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Pharmacology (714 citations), Pharmacology (363 citations), Analytical Chemistry (153 citations), Psychiatry and Mental health (223 citations) and Biochemistry (97 citations). MS Lennard has collaborated with scholars based in United Kingdom, Sri Lanka and United States. Frequent co-authors include GT Tucker, HF Woods, R. E. Haddock, JH Silas, H.K. Crewe, S Freestone, LE Ramsay, PR Jackson, Clare E. Casey and Elizabeth M. J. Gillam. Their work appears in journals such as British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.